Institute of Vaccine and Medical Biologicals (IVAC) in the central province of Khanh Hoa yesterday announced its vaccine against H5N1 flu viruses is qualified after clinical tests.
Dr Le Van Be, head of the Institute, said that the vaccine will be put in clinical tests further; currently, the institute is asking for license issued by the Biomedical Advanced Research and Development Authority (BARDA), the World Health Organization (WHO) and PATH, an international health organization driving transformative innovation to save lives.
After the institute receives the license, the vaccine will go into mass production to meet the country’s demand and the world’s when the disease occurs.
Before, in May 2011, with the assistance of experts from WHO, after five years of construction, the Health Ministry’s IVAC inaugurated a flu vaccine plant in Khanh Hoa Province. It is the first of its kind in Vietnam.
Currently, the WHO-funded plant studies and produces influenza vaccines at a capacity of 1-3 million doses per year.
H5N1 is a type of influenza virus that causes a highly infectious, severe respiratory disease in birds called avian influenza (as known as bird flu). Human cases of H5N1 avian influenza occur occasionally, but it is difficult to transmit the infection from person to person. When people do become infected, the mortality rate is about 60 percent, according to the WHO.